Topic hub

Why patients stay on a medicine, and why they stop

Adherence as patients describe it: side effects, cost, routine, and the moment a prescription quietly lapses.

6 insights·0 studies

What did the panels say about why patients stay on a medicine, and why they stop?

  1. #

    48.5%

    48.5% would stop the blood pressure pill once its copay rose from $15 to $60 a month, on top of no felt benefit and afternoon tiredness, up from 14.0% with the tiredness alone and 1.5% with no felt benefit alone. — Patient adherence breaks at the copay: 48.5% would stop a daily blood pressure pill when it jumps from $15 to $60 a month

    base 200

  2. #

    35%

    35.0% would stay on an antidepressant that is helping at $150 a month, against 82.2% at $50 and 97.0% at $10; no clone rates itself more likely to stay on at a higher price. — Antidepressant cost: only 35.0% of US adults prescribed one for depression would stay on it at $150 a month, against 82.2% at $50

    base 197

  3. #

    98%

    A follow-up blood test showing cholesterol down by a third lifts the share of US adults very likely to still be taking a daily statin a year later from 74.5% to 98.0%; automatic home delivery every three months at the same $10 a month lifts it to 80.5%. Every case had no side effects and no change in how the person feels. — Seeing it work keeps US adults on a statin they cannot feel: a cholesterol test result wins over 92.2% of those not yet certain, home delivery 27.5%, and a $30 a month rise is the top reason to stop below $50,000 a year

    base 200

  4. #

    67%

    67.0% say worry about side effects would most hold them back from starting a statin their doctor recommends while they feel well; 19.5% would rather try diet and exercise first and 2.5% name the monthly cost. — Side-effect fears hold back 67.0% of US adults from a recommended statin, and a test of their own heart risk, not a lower price, is what would change their minds

    base 200

  5. #

    0

    There is no cheap nudge. Not one person in 200 would proceed for less than $1,000. — Cash to go ahead with a delayed $3,000 treatment: no US adult would for under $1,000, and 97 of 200 would need the full $3,000

    base 200

What has Brox published on why patients stay on a medicine, and why they stop?Newest first

What do people ask about why patients stay on a medicine, and why they stop?

Why do patients stop taking a daily medicine after the first few months, and what would keep them on it?
48.5% of US adults who take a daily prescription medicine (n=200, November 2026) would stop a new blood pressure pill once its copay rose from $15 to $60 a month on top of no felt benefit and afternoon tiredness, against 14.0% before the copay rise and 1.5% with no side effect at all.Read the insight
Why do US adults with depression stop an antidepressant, and what would have kept them on it?
Cost and side effects: 82.2% of US adults prescribed an antidepressant for depression would stay on one that helps at $50 a month but 35.0% at $150, and 51.3% say a quick switch when side effects bother them would keep them on it (n=197, November 2026).Read the insight
What makes a patient with high cholesterol take a statin every day when they feel fine?
Seeing it work keeps US adults on a daily statin they feel no different on: a follow-up blood test showing cholesterol down by a third lifts the share very likely to still be taking it a year later from 74.5% to 98.0% (n=200, October 2026), while automatic home delivery lifts it only to 80.5%.Read the insight
What stops patients starting a preventive medicine their doctor has recommended?
Worry about side effects is the main thing that would stop 67.0% of US adults starting a daily statin their doctor recommends while they feel well (n=200, October 2026), while 62.5% say a test showing their own heart risk is high would most persuade them to start, against 1.0% who name a lower price.Read the insight
When a health plan deductible leaves a needed treatment costing about $3,000 out of pocket, how large does a cash payment have to be before people go ahead with it, and does it matter whether the money arrives before or after the treatment?
Not one of 200 US adults would go ahead with a $3,000 treatment they had been putting off for a cash payment under $1,000, and 97 of the 200 need the full $3,000 back, September 2026.Read the insight
Where do people move their prescriptions when the pharmacy store filling them closes, and what would keep them with the same chain?
89% of US pharmacy users (178 of 200) would keep their prescriptions with the same chain when their store closes, and a guarantee the prescription is ready on time is the strongest thing that holds them (75.5%), while a discount is the weakest (36.5%), September 2026.Read the insight

Other topics

How should you read these findings?

Where the numbers come from. Every figure on this site is a predicted response from Brox clones: behavioural replicas of real people, each built from a long-form interview with that person. The base under each figure is the number of clones behind it.

Where the real data comes from. The long-form video interviews with the real people the clones are built from. A quote is always shown with the interview line it was predicted from.

What you can take away. Insights publish their tabulation as CSV and JSON: question, option, count, percentage and base. Never per-person rows.

Ask this of your own customers: humans@brox.ai